GNMSF GENMAB A/S
NEUTRAL
Impact: 3/10
6-K
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GNMSF ▼ -5.85% at T+20d
NEUTRAL call ✗ call lost -5.85% · α vs SPY -11.22% · entry $281.75 → $265.27
Last close $258.12 (close May 22) · -8.39% from $281.75 entry
T+1d
0.00%
call 0.00% · α +0.19%
$281.75
settled 5w ago
T+5d
-3.52%
call -3.52% · α -4.08%
$271.83
settled 4w ago
T+20d
-5.85%
call -5.85% · α -11.22%
$265.27
settled 9d ago
T+60d
—
call — · α —
—
in 7w
Price Chart
Loading chart...
Executive Summary
Genmab AS filed an updated version of its Articles of Association, incorporating amendments made on March 19, 2026, including the issuance of warrants to employees and updates to capital authorization. This is a routine corporate update.
Actionable Insight
No immediate trading implications. This is a routine administrative filing. Traders should focus on upcoming financial results or clinical trial data for material updates.
Key Facts
- Filing is an updated English translation of Genmab's Articles of Association, effective March 19, 2026.
- The document incorporates historical warrant issuances and authorizations, including a grant of 4,485 shares on March 19, 2026.
- No new material agreements, financial results, or executive changes are announced.
- This is a standard 6-K filing to provide updated corporate governance documents to the SEC.
Financial Impact
None disclosed. The filing is a procedural update of existing articles and historical warrant grants.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000065 |
| Document: gmab_2026417x6k.htm | 0001434265-26-000065 |
| Document: 0001434265-26-000065-index-headers.html | 0001434265-26-000065 |
| Document: 0001434265-26-000065-index.html | 0001434265-26-000065 |
| Document: 0001434265-26-000065.txt | 0001434265-26-000065 |
9 reports for GNMSF
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 13, 2026
10d ago
|
6-K
| $268.24 $265.27 | ▼ −1.11% | ▲ +0.05% | $258.12 (−3.77%) |
|
May 12, 2026
11d ago
|
6-K
| $264.64 $265.27 | ▲ +0.24% | ▲ +0.16% | $258.12 (−2.46%) |
|
May 8, 2026
15d ago
|
6-K
| $259.60 $265.27 | ▲ +2.18% | ▲ +2.27% | $258.12 (−0.57%) |
|
Apr 17, 2026
5w ago
|
6-K
| $281.75 $271.83 | ▼ −3.52% | ▼ −4.08% | $258.12 (−8.39%) |
|
Apr 17, 2026
5w ago
|
6-K
| $281.75 $271.83 | ▼ −3.52% | ▼ −4.08% | $258.12 (−8.39%) |
|
Apr 14, 2026
5w ago
|
6-K
| $273.25 $281.75 | ▲ +3.11% | ▲ +1.72% | $258.12 (−5.54%) |
|
Apr 1, 2026
7w ago
|
6-K
| $265.00 $298.38 | ▲ +12.60% | ▲ +8.83% | $258.12 (−2.60%) |
|
Apr 1, 2026
7w ago
|
6-K
| $265.00 $298.38 | ▲ +12.60% | ▲ +8.83% | $258.12 (−2.60%) |
|
Mar 30, 2026
7w ago
|
6-K
| $265.00 $281.06 | ▲ +6.06% | ▲ +2.12% | $258.12 (−2.60%) |
Showing 9 of 9
US Market Status
Market Closed — Opens Tue (35h 15m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access